MEXICO CITY (Reuters) – Mexico aims to have developed a vaccine against COVID-19 that could be granted approval for emergency use this year, a senior official said on Tuesday, an outcome that could wean it off unreliable foreign supplies for…
Read More
What Drives Treatment Satisfaction Among Adults With AD?
Atopic dermatitis (AD) is associated with lower patient satisfaction scores in adults, suggesting there are unmet needs in clinical AD management. Satisfaction scores were higher when specialists prescribed systemic therapy, but were lower when nonspecialists prescribed systemic therapy and when…
Read More
US NIH Halts Trial Testing COVID-19 Blood Plasma
(Reuters) — The U.S. National Institutes of Health (NIH) said on Tuesday it had halted a trial testing convalescent blood plasma in treatment of patients with mild to moderate COVID-19 symptoms. The NIH said an independent data monitoring board found…
Read More
Delaying second COVID-19 vaccine doses will make supplies last longer but comes with risks
During Pfizer-BioNTech’s vaccine trial, one vaccinated participant and nine who received a placebo developed a severe case of COVID-19 after the first dose. This suggests that participants developed partial protection as early as 12 days after the first dose. However,…
Read More